209 related articles for article (PubMed ID: 32794364)
21. The efficacy of botulinum toxin A in the treatment of Raynaud's phenomenon in systemic sclerosis: A randomized self-controlled trial.
Du W; Zhou M; Zhang C; Sun Q
Dermatol Ther; 2022 Jul; 35(7):e15529. PubMed ID: 35441772
[TBL] [Abstract][Full Text] [Related]
22. A prospective study of the use of botulinum toxin injections in the treatment of Raynaud's syndrome associated with scleroderma.
Uppal L; Dhaliwal K; Butler PE
J Hand Surg Eur Vol; 2014 Oct; 39(8):876-80. PubMed ID: 24369360
[TBL] [Abstract][Full Text] [Related]
23. Raynaud's phenomenon of the nipple: a treatable cause of painful breastfeeding.
Anderson JE; Held N; Wright K
Pediatrics; 2004 Apr; 113(4):e360-4. PubMed ID: 15060268
[TBL] [Abstract][Full Text] [Related]
24. Botox therapy for ischemic digits.
Neumeister MW; Chambers CB; Herron MS; Webb K; Wietfeldt J; Gillespie JN; Bueno RA; Cooney CM
Plast Reconstr Surg; 2009 Jul; 124(1):191-201. PubMed ID: 19568080
[TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin in the management of primary and secondary Raynaud's phenomenon.
Ennis D; Ahmad Z; Anderson MA; Johnson SR
Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101684. PubMed ID: 33965340
[TBL] [Abstract][Full Text] [Related]
26. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
Colakoğlu M; Cobankara V; Akpolat T
Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
[TBL] [Abstract][Full Text] [Related]
27. Raynaud's phenomenon of fingers and toes among vibration-exposed patients.
Toibana N; Ishikawa N; Sakakibara H; Yamada S
Nagoya J Med Sci; 1994 May; 57 Suppl():121-8. PubMed ID: 7708094
[TBL] [Abstract][Full Text] [Related]
28. [Raynaud's phenomena: diagnostic and treatment study].
Priollet P
Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
[TBL] [Abstract][Full Text] [Related]
29. Nipple pain: Raynaud's beyond fingers and toes.
Di Como J; Tan S; Weaver M; Edmonson D; Gass JS
Breast J; 2020 Oct; 26(10):2045-2047. PubMed ID: 32755067
[TBL] [Abstract][Full Text] [Related]
30. Management of Raynaud's digital ulcer with interdigital Botulinum toxin A injection.
Navarro EP; Cañas CA; Tobón GJ
Rheumatology (Oxford); 2016 Jul; 55(7):1216. PubMed ID: 27155203
[No Abstract] [Full Text] [Related]
31. The role of botulinum toxin in vasospastic disorders of the hand.
Neumeister MW
Hand Clin; 2015 Feb; 31(1):23-37. PubMed ID: 25455354
[TBL] [Abstract][Full Text] [Related]
32. Raynaud's phenomenon.
Devgire V; Hughes M
Br J Hosp Med (Lond); 2019 Nov; 80(11):658-664. PubMed ID: 31707892
[TBL] [Abstract][Full Text] [Related]
33. Raynaud's phenomenon (secondary).
Herrick A; Muir L
BMJ Clin Evid; 2014 Oct; 2014():. PubMed ID: 25322727
[TBL] [Abstract][Full Text] [Related]
34. Botulinum Toxin A Treatment for Primary and Secondary Raynaud's Phenomenon in Teenagers.
Quintana Castanedo L; Feito Rodríguez M; Nieto Rodríguez D; Maseda Pedrero R; Chiloeches Fernández C; de Lucas Laguna R
Dermatol Surg; 2021 Jan; 47(1):61-64. PubMed ID: 32371783
[TBL] [Abstract][Full Text] [Related]
35. Difficulties in diagnosis and treatment of severe secondary Raynaud's phenomenon in a Cameroonian woman: a case report.
Agbor VN; Njim T; Aminde LN
J Med Case Rep; 2016 Dec; 10(1):356. PubMed ID: 27998297
[TBL] [Abstract][Full Text] [Related]
36. Pharmacotherapy of Raynaud's phenomenon.
Belch JJ; Ho M
Drugs; 1996 Nov; 52(5):682-95. PubMed ID: 9118818
[TBL] [Abstract][Full Text] [Related]
37. Novel Combined Approach for Digital Necrosis Secondary to Raynaud's Phenomenon.
Vegas DH; Fabiani MA; Gonzalez-Urquijo M; Bignotti A; Seré I; Salvadores P
Vasc Endovascular Surg; 2021 Oct; 55(7):766-771. PubMed ID: 33866879
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of botulinum toxin in treating scleroderma-associated raynaud's phenomenon: a systematic review and meta-analysis.
Elrosasy A; Abo Zeid M; Cadri S; Fahmy BM; Elzeftawy MA; Mohammed F; Ramadan A
Arch Dermatol Res; 2024 Apr; 316(5):122. PubMed ID: 38630277
[No Abstract] [Full Text] [Related]
39. OnabotulinumtoxinA for Systemic Sclerosis-associated Raynaud's Phenomenon: A Multi-Institutional Study on Accessibility and Effectiveness.
Kassamali B; Desai S; Min M; Mazori D; Villa-Ruiz C; Kus K; Cobos G; Merola J; LaChance A; Vleugels R
J Drugs Dermatol; 2021 Nov; 20(11):1257-1259. PubMed ID: 34784129
[TBL] [Abstract][Full Text] [Related]
40. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
